Figures & data
Figure 1 Platelet count over time. Enoxaparin therapy was started on hospital day 13 and discontinued on hospital day 19.
![Figure 1 Platelet count over time. Enoxaparin therapy was started on hospital day 13 and discontinued on hospital day 19.](/cms/asset/dbe36430-0a2b-4020-aced-5f2e48bc51e4/dcpa_a_12164206_f0001_b.jpg)
Figure 2 Selections for each criterion in the Naranjo Score are bolded. A score of 7 suggests a probable adverse drug reaction. 1While no conclusive evidence exists to support this reaction, it has been previously seen in other populations and has been reported in the literature previously. 2While there are alternative causes for secondary thrombocytosis, we were able to exclude them in our case leaving enoxaparin as the most likely cause.
![Figure 2 Selections for each criterion in the Naranjo Score are bolded. A score of 7 suggests a probable adverse drug reaction. 1While no conclusive evidence exists to support this reaction, it has been previously seen in other populations and has been reported in the literature previously. 2While there are alternative causes for secondary thrombocytosis, we were able to exclude them in our case leaving enoxaparin as the most likely cause.](/cms/asset/86a7bc23-4f52-4b9e-88f9-b37032817bee/dcpa_a_12164206_f0002_c.jpg)